Literature DB >> 21389123

The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency.

Xianming Yu1, Patrick J McCarthy, Hui-Jun Lim, Tawin Iempridee, Richard J Kraus, Daniel A Gorlen, Janet E Mertz.   

Abstract

The Epstein-Barr virus (EBV) BZLF1 gene encodes the immediate-early (IE) protein Zta, which plays a central role in regulating the switch between viral latency and lytic replication. A silencing element, ZIIR, is located between the ZID and ZII positive regulatory elements in the BZLF1 promoter Zp. We report here the phenotypes of variants of EBV strain B95.8 containing base substitution mutations in this ZIIR element. HEK293 cells infected with ZIIR mutant (ZIIRmt) virus produced at least 20-fold more viral IE Zta and Rta and early (E) EAD protein than did cells infected with the parental wild-type (WT) virus, leading to viral DNA replication and production of infectious virus. However, ZIIR mutant virus was 1/10 as efficient as WT virus in establishing proliferating B-cell clones following infection of human primary blood B cells. The ZIIRmt-infected lymphoblastoid cell lines (LCLs) that did grow out exhibited a phenotype similar to the one observed in 293 cells, including marked overproduction of IE and E gene products relative to WT-infected LCLs and lytic replication of the viral genome. Incubation of the ZIIRmt-infected LCLs with the chemical inducer 12-O-tetradecanoyl-phorbol-13-acetate (TPA) led to much greater activation of Zp than did the same treatment of WT- or ZVmt-infected LCLs. Furthermore, a protein kinase C (PKC) inhibitor, bis-indolylmaleimide, eliminated this activation by TPA. Thus, we conclude that ZIIR is a potent silencing element of Zp; it plays a key role in establishment and maintenance of EBV latency by inhibiting activation of Zp through the PKC signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389123      PMCID: PMC3126197          DOI: 10.1128/JVI.02615-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Rapid engineering of bacterial artificial chromosomes using oligonucleotides.

Authors:  S Swaminathan; H M Ellis; L S Waters; D Yu; E C Lee; D L Court; S K Sharan
Journal:  Genesis       Date:  2001-01       Impact factor: 2.487

2.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.

Authors:  Richard J Kraus; Jacqueline G Perrigoue; Janet E Mertz
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase.

Authors:  X Gao; K Ikuta; M Tajima; T Sairenji
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

5.  Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.

Authors:  B Neuhierl; R Feederle; W Hammerschmidt; H J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

6.  Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.

Authors:  Lyndle Gradoville; David Kwa; Ayman El-Guindy; George Miller
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.

Authors:  Amy L Ellis-Connell; Tawin Iempridee; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

8.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency.

Authors:  Nathaniel J Moorman; David O Willer; Samuel H Speck
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency.

Authors:  Cornelia Thomas; Arnd Dankesreiter; Hans Wolf; Fritz Schwarzmann
Journal:  J Gen Virol       Date:  2003-04       Impact factor: 3.891

View more
  11 in total

1.  Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.

Authors:  Nicholas J Homa; Raul Salinas; Eleonora Forte; Timothy J Robinson; Mariano A Garcia-Blanco; Micah A Luftig
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.

Authors:  Shi-Dong Ma; Xianming Yu; Janet E Mertz; Jenny E Gumperz; Erik Reinheim; Ying Zhou; Weihua Tang; William J Burlingham; Margaret L Gulley; Shannon C Kenney
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.

Authors:  Xianming Yu; Patrick J McCarthy; Zhenxun Wang; Daniel A Gorlen; Janet E Mertz
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 5.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

6.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.

Authors:  Richard J Kraus; Xianming Yu; Blue-Leaf A Cordes; Saraniya Sathiamoorthi; Tawin Iempridee; Dhananjay M Nawandar; Shidong Ma; James C Romero-Masters; Kyle G McChesney; Zhen Lin; Kathleen R Makielski; Denis L Lee; Paul F Lambert; Eric C Johannsen; Shannon C Kenney; Janet E Mertz
Journal:  PLoS Pathog       Date:  2017-06-15       Impact factor: 6.823

9.  Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin.

Authors:  Chung-Chun Wu; Chih-Yeu Fang; Yu-Jhen Cheng; Hui-Yu Hsu; Sheng-Ping Chou; Sheng-Yen Huang; Ching-Hwa Tsai; Jen-Yang Chen
Journal:  J Biomed Sci       Date:  2017-01-05       Impact factor: 8.410

10.  Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.

Authors:  Richard J Kraus; Blue-Leaf A Cordes; Saraniya Sathiamoorthi; Parita Patel; Xueying Yuan; Tawin Iempridee; Xianming Yu; Denis L Lee; Paul F Lambert; Janet E Mertz
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.